Xiaobing Miao

516 total citations
22 papers, 356 citations indexed

About

Xiaobing Miao is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Xiaobing Miao has authored 22 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Xiaobing Miao's work include Multiple Myeloma Research and Treatments (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and RNA Research and Splicing (5 papers). Xiaobing Miao is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and RNA Research and Splicing (5 papers). Xiaobing Miao collaborates with scholars based in China. Xiaobing Miao's co-authors include Yaxun Wu, Yuchan Wang, Xinghua Zhu, Song He, Chunsun Li, Xiaoyun Lu, Yushan Liu, Nong Zhang, Xiaohong Xu and Yali Chen and has published in prestigious journals such as Experimental Cell Research, International Journal of Biological Macromolecules and Frontiers in Oncology.

In The Last Decade

Xiaobing Miao

20 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaobing Miao China 12 237 100 96 71 47 22 356
Elisabeth Emilsen Norway 10 280 1.2× 167 1.7× 80 0.8× 60 0.8× 39 0.8× 17 428
Janice M. Mehnert United States 8 303 1.3× 183 1.8× 58 0.6× 52 0.7× 40 0.9× 24 409
Swarna Mehrotra United States 7 269 1.1× 147 1.5× 66 0.7× 115 1.6× 19 0.4× 7 409
Valerie Morris United States 8 178 0.8× 108 1.1× 70 0.7× 49 0.7× 31 0.7× 16 311
Omer Gilan Australia 10 253 1.1× 93 0.9× 92 1.0× 43 0.6× 20 0.4× 13 362
Eylül Tuncer Switzerland 6 365 1.5× 115 1.1× 105 1.1× 94 1.3× 23 0.5× 6 472
Alice D. Baudot United Kingdom 9 265 1.1× 65 0.7× 49 0.5× 67 0.9× 28 0.6× 10 427
Lajos Berczi Hungary 10 191 0.8× 125 1.3× 65 0.7× 90 1.3× 55 1.2× 18 378
Buyou Chen China 16 386 1.6× 109 1.1× 149 1.6× 100 1.4× 29 0.6× 23 523
Hannah J. Whiteman United Kingdom 7 250 1.1× 152 1.5× 109 1.1× 89 1.3× 23 0.5× 7 409

Countries citing papers authored by Xiaobing Miao

Since Specialization
Citations

This map shows the geographic impact of Xiaobing Miao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobing Miao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobing Miao more than expected).

Fields of papers citing papers by Xiaobing Miao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobing Miao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobing Miao. The network helps show where Xiaobing Miao may publish in the future.

Co-authorship network of co-authors of Xiaobing Miao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobing Miao. A scholar is included among the top collaborators of Xiaobing Miao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobing Miao. Xiaobing Miao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wu, Yaxun, et al.. (2024). Role of four and a half LIM domain protein 1 in tumors (Review). Oncology Letters. 29(1). 37–37.
3.
Xu, Xiaohong, et al.. (2023). Roles of ubiquitin‑specific protease 13 in normal physiology and tumors (Review). Oncology Letters. 27(2). 58–58. 3 indexed citations
4.
Shen, Rong, et al.. (2023). Expression and role of FKBPL in lung adenocarcinoma. Journal of Cancer. 15(1). 166–175. 1 indexed citations
5.
Gu, Qianhui, Jing Li, Zhuolin Chen, et al.. (2021). Expression and Prognostic Significance of PD-L2 in Diffuse Large B-Cell Lymphoma. Frontiers in Oncology. 11. 664032–664032. 10 indexed citations
6.
Miao, Xiaobing & Nong Zhang. (2020). Role of RBM3 in the regulation of cell proliferation in hepatocellular carcinoma. Experimental and Molecular Pathology. 117. 104546–104546. 17 indexed citations
7.
Zhu, Xinghua, Yaxun Wu, Xiaobing Miao, et al.. (2016). High expression of TRIM44 is associated with enhanced cell proliferation, migration, invasion, and resistance to doxorubicin in hepatocellular carcinoma. Tumor Biology. 37(11). 14615–14628. 40 indexed citations
8.
Miao, Xiaobing, Yaxun Wu, Yingze Wei, et al.. (2016). The role of the Chaperonin containing t-complex polypeptide 1, subunit 8 (CCT8) in B-cell non-Hodgkin's lymphoma. Leukemia Research. 45. 59–67. 15 indexed citations
9.
Miao, Xiaobing, Yaxun Wu, Yuchan Wang, et al.. (2016). Y-box-binding protein-1 (YB-1) promotes cell proliferation, adhesion and drug resistance in diffuse large B-cell lymphoma. Experimental Cell Research. 346(2). 157–166. 36 indexed citations
10.
11.
He, Song, Xiaobing Miao, Yaxun Wu, et al.. (2015). Upregulation of nuclear transporter, Kpnβ1, contributes to accelerated cell proliferation- and cell adhesion-mediated drug resistance (CAM-DR) in diffuse large B-cell lymphoma. Journal of Cancer Research and Clinical Oncology. 142(3). 561–572. 19 indexed citations
12.
13.
Wang, Yuchan, Yaxun Wu, Xiaobing Miao, et al.. (2015). Silencing of DYRK2 increases cell proliferation but reverses CAM-DR in Non-Hodgkin's Lymphoma. International Journal of Biological Macromolecules. 81. 809–817. 14 indexed citations
14.
Tang, Qiyun, Xiaobing Miao, Yaxun Wu, et al.. (2015). ErbB3 binding protein 1 (EBP1) participates in the regulation of intestinal inflammation via mediating Akt signaling pathway. Molecular Immunology. 67(2). 540–551. 11 indexed citations
15.
Tang, Jie, Chun Wang, Li Zhu, et al.. (2015). Cell adhesion downregulates the expression of Homer1b/c and contributes to drug resistance in multiple myeloma cells. Oncology Reports. 35(3). 1875–1883. 2 indexed citations
16.
Tang, Jie, Lili Ji, Yuchan Wang, et al.. (2015). Cell adhesion down-regulates the expression of vacuolar protein sorting 4B (VPS4B) and contributes to drug resistance in multiple myeloma cells. International Journal of Hematology. 102(1). 25–34. 8 indexed citations
17.
Wang, Yuchan, Hong Liu, Xiaohong Xu, et al.. (2015). Pyruvate kinase isoform M2 (PKM2) participates in multiple myeloma cell proliferation, adhesion and chemoresistance. Leukemia Research. 39(12). 1428–1436. 39 indexed citations
18.
Ni, Runzhou, Xiaobing Miao, Liang Wang, et al.. (2015). Epithelial-specific ETS-1 (ESE1/ELF3) regulates apoptosis of intestinal epithelial cells in ulcerative colitis via accelerating NF-κB activation. Immunologic Research. 62(2). 198–212. 26 indexed citations
19.
Zhu, Xinghua, Xiaobing Miao, Yaxun Wu, et al.. (2015). ENO1 promotes tumor proliferation and cell adhesion mediated drug resistance (CAM-DR) in Non-Hodgkin's Lymphomas. Experimental Cell Research. 335(2). 216–223. 51 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisabeth Emilsen Breakdown of academic impact, for papers by Janice M. Mehnert Breakdown of academic impact, for papers by Swarna Mehrotra Breakdown of academic impact, for papers by Valerie Morris Breakdown of academic impact, for papers by Omer Gilan Breakdown of academic impact, for papers by Eylül Tuncer Breakdown of academic impact, for papers by Alice D. Baudot Breakdown of academic impact, for papers by Lajos Berczi Breakdown of academic impact, for papers by Buyou Chen Breakdown of academic impact, for papers by Hannah J. Whiteman
Rankless by CCL
2026